Smiley face
COVID-19 Education and Awareness Panel to be Held May 21st
May17

COVID-19 Education and Awareness Panel to be Held May 21st

A COVID-19 Education and Awareness Panel, presented by The University of Texas at Tyler, Ben and Maytee Fisch with the College of Pharmacy, and Care Wellness, will be held May 21st, 10am to 1pm, at MLK Drive Church of Christ. Come join the discussion with healthcare professions about the fears and doubts of COVID-19 vaccines. Vaccines will be provided. COVID 19 Education and Awareness Panel

Read More
FDA Authorizes EAU Of Pfizer COVID-19 Single-Dose Booster For Kids 5-11 Years Old
May17

FDA Authorizes EAU Of Pfizer COVID-19 Single-Dose Booster For Kids 5-11 Years Old

US FDA news release – Tuesday, May 17, 2022 Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine, authorizing the use of a single booster dose for administration to individuals 5 through 11 years of age at least five months after completion of a primary series with the Pfizer-BioNTech COVID-19 Vaccine.  “While it has largely been the case that...

Read More
FDA Authorizes First COVID-19 Test Available Without Prescription That Also Detects Flu, RSV
May16

FDA Authorizes First COVID-19 Test Available Without Prescription That Also Detects Flu, RSV

The EUA Authorizes At-Home Sample Collection With Testing Performed In A Laboratory FDA NEWS RELEASE – Monday, May 16, 2022 Today, the U.S. Food and Drug Administration authorized the Labcorp Seasonal Respiratory Virus RT-PCR DTC Test for use without a prescription by individuals with symptoms of respiratory viral infection consistent with COVID-19. This product is the first direct-to-consumer (non-prescription) multi-analyte...

Read More
Coronavirus (COVID-19) Update: FDA Approves First COVID-19 Treatment For Young Children
Apr25

Coronavirus (COVID-19) Update: FDA Approves First COVID-19 Treatment For Young Children

Today, the U.S. Food and Drug Administration expanded the approval to Gilead Sciences Inc. of the COVID-19 treatment Veklury (remdesivir) to include pediatric patients 28 days of age and older weighing at least 3 kilograms (about 7 pounds) with positive results of direct SARS-CoV-2 viral testing, who are: Hospitalized, orNot hospitalized and have mild-to-moderate COVID-19 and are at high risk for progression to severe COVID-19,...

Read More
Alcohol Isn’t The Only Thing A Breath Test Can Detect; It Can Now Detect COVID-19 Too
Apr14

Alcohol Isn’t The Only Thing A Breath Test Can Detect; It Can Now Detect COVID-19 Too

Alcohol isn’t the only thing a breath test can detect; COVID-19 can now be detected in less than 3 minutes using a breath sample. Not having to stick a long cotton swab up the nose, have a blood sample drawn or cheek swab to check for the virus sounds great, just don’t expect to see the new diagnostic devices readily available to the average consumer anytime soon – or even some locations that previously conducted...

Read More
USFDA Authorizes Second Booster Dose Of Pfizer, Moderna COVID-19 Vaccines For Ages 50 And Up And Immunocompromised Individuals
Mar29

USFDA Authorizes Second Booster Dose Of Pfizer, Moderna COVID-19 Vaccines For Ages 50 And Up And Immunocompromised Individuals

Today (March 28, 2022), the U.S. Food and Drug Administration authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and certain immunocompromised individuals. The FDA previously authorized a single booster dose for certain immunocompromised individuals following completion of a three-dose primary vaccination series. This makes a second booster dose of both vaccines available...

Read More
Free COVID-19 Vaccinations Offered Feb. 9 By Hopkins County Emergency Management
Feb09

Free COVID-19 Vaccinations Offered Feb. 9 By Hopkins County Emergency Management

Free COVID-19 vaccinations will be offered from 10 a.m. to 1 p.m. Feb. 9, 2022, by Hopkins County Emergency Management at 128-A Jefferson Street in Sulphur Springs. Booster vaccines will also be available at the event. The clinic is for adults, students and children 5 and older. No insurance is required, but a parent or guardian must attend with children. Register in person at the event.

Read More
CHRISTUS Mother Frances Hospital – Sulphur Springs Partners With NETX Public Health District To Offer Pediatric COVID-19 Vaccinations
Feb07

CHRISTUS Mother Frances Hospital – Sulphur Springs Partners With NETX Public Health District To Offer Pediatric COVID-19 Vaccinations

Sulphur Springs, Texas, February 7, 2022 – CHRISTUS Mother Frances Hospital – Sulphur Springs will be partnering with Northeast Texas Public Health District to provide COVID vaccinations for children ages 5 through 11. The vaccine clinic will be held in the MMU tent located in the parking lot north of the hospital (between Dr. Arnecke and Podiatry offices) from 10 a.m. until 3 p.m. during the week of February 7. The second vaccine in...

Read More
COVID-19 Vaccinations For Children Ages 5-11 Offered In MMU Tent Each Morning This Week
Jan31

COVID-19 Vaccinations For Children Ages 5-11 Offered In MMU Tent Each Morning This Week

CHRISTUS Mother Frances Hospital – Sulphur Springs Business News –January 31, 2022 By Holly Ragan, Senior Market Development, CHRISTUS Mother Frances Hospital – Sulphur Springs, [email protected] COVID Testing at CHRISTUS Trinity Clinics | Urgent Care Due to a shortage of COVID testing supplies, we unfortunately cannot guarantee that rapid tests will be available.  If rapid tests are not available, we will be able...

Read More
FDA Approves Second COVID-19 Vaccine
Jan31

FDA Approves Second COVID-19 Vaccine

News Release – Monday, Jan. 31, 2022 Moderna To Be Marketed as Spikevax COVID-19 Vaccine For Ages 18+ Today (Jan. 31, 2022), the U.S. Food and Drug Administration approved a second COVID-19 vaccine. The vaccine has been known as the Moderna COVID-19 Vaccine; the approved vaccine will be marketed as Spikevax for the prevention of COVID-19 in individuals 18 years of age and older.  Key points Spikevax meets the FDA’s rigorous...

Read More